Department of Error (DOI:10.1016/S0140-6736(09)61471-9);Who is ineligible for warfarin in atrial fibrillation?

The Lancet

Volumn 374, Issue 9689, 2009, Pages 510-511

  Verheugt, Freek WA ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD PRESSURE; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; STROKE;

EID: 68549133614     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61747-5     Document Type: Erratum

References (9)

1. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: a major contributor to stroke: the Framingham Study. Arch Intern Med 147 (1987) 1561-1564
2. Lip G.Y., Hart R.G., and Conway D.S. Antithrombotic therapy for atrial fibrillation. BMJ 325 (2002) 1022-1025
3. Verheugt F. Can we pull the plug for warfarin in atrial fibrillation?. Lancet 362 (2003) 1686-1687
4. CURE Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
5. Sabatine M., Cannon C.P., Montalescot G., et al., for the CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
6. COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1607-1621
7. ACTIVE Investigators. Randomized controlled trial of clopidogrel plus aspirin versus oral anticoagulation in patients with atrial fibrillation: The Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE). Lancet 367 (2006) 1903-1912
8. ACTIVE Investigators. Effect of clopidogrel added to aspirin in atrial fibrillation. N Engl J Med 360 (2009) 2066-2078
9. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870